Centre revokes licences of three vaccine units

The PSUs failed to comply with good manufacturing practices

GN Bureau | March 3, 2010



The centre has lifted the suspension of licences of three public sector vaccine units that were closed in 2008 for failing to comply with good manufacturing practices (GMP). The order will come into effect immediately, reported The Hindu. The licence revocation comes almost two years after the units appealed against their closure.

The ministry of health and family welfare revoked the suspension on February 12 for disposing of stocks both finished products and raw material subject to their being certified fit for human use. The government took into account "the impact in the post-suspension era in terms of availability and prices of these vaccines on the universal immunisation programme and the public interest involved in maintaining the captive production capacity of these units."

The Central Research Institute at Kasauli in Himachal Pradesh, the Pasteur Institute of India at Coonoor in Tamil Nadu and the BCG Vaccine Laboratory in Chennai have been asked to make their production line fully GMP-compliant within three years. They will have to furnish Quarterly reports on the progress made in these three years. Their manufacturing licences were suspended on January 15, 2008.

The suspension of licences of these units came under criticism from Left parties as it resulted in acute shortage and also increased prices in the open market. These units accounted for 80 percent supplies for the universal immunisation programme.

Comments

 

Other News

Trump’s China setback pushes US to woo India

A week after Donald Trump’s visit to China – the first by an American president in nine years, US secretary of state Marco Rubio arrived in India on May 23 on a four-day visit aimed at resetting Washington DC’s relations with New Delhi and attending the third Quad ministerial meeting.

EU–India FTA 2026: A high‑stakes prescription for Indian pharma and healthcare

India’s pharmaceutical industry stands as one of the world’s market leaders of generic pharmacy with market valuation of USD 50 billion in 2026. Characterised by high volume, low-cost generic manufacturing, with an annual growth rate of 10-12% primarily propelled by exports and domestic demand,

Legends, vignettes and tales from the freedom movement

Robin Hood of Kathiawar and Other Extraordinary Stories from India’s Freedom Movement By The Paperclip  HarperCollins, 348 pages, Rs 499  

Solicitor General Tushar Mehta tells quirky tales from the world of law

The Lawful and the Awful: Quirky Tales from the World of Law By Tushar Mehta Rupa Publications, 336 pages, Rs 995  

Cabinet meet discussed `Ease of Living`, `Ease of Doing Business`

The Council of Ministers has deliberated upon valuable perspectives and best practices relating to boosting ‘Ease of Living’ and ‘Ease of Doing Business’, prime minister Narendra Modi said on Friday.   As he shared details of the Council meeting held the d

India should deepen energy partnerships with Africa

The vulnerability of Strait of Hormuz continues to influence energy politics globally. India is highly dependent on imported crude oil as a significant portion of its oil imports still come from the Gulf ultimately making such disruptions particularly consequential and has immediate economic ramifications


Archives

Current Issue

Opinion

Facebook Twitter Google Plus Linkedin Subscribe Newsletter

Twitter